#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Heritable pulmonary arterial hypertension Friedreich's ataxia Trigeminal neuralgia Postprandial hypoglycaemia Peritoneal neoplasm Pericarditis Metastases to peritoneum Systemic lupus erythematosus High-grade B-cell lymphoma Hepatoblastoma Anti-myelin-associated glycoprotein associated polyneuropathy Primary adrenal insufficiency Extra-osseous Ewing's sarcoma Laryngeal squamous cell carcinoma Fontan procedure More trials…

    Learn about Rare Diseases

    Congenital hypotransferrinaemia Synovial sarcoma – Diagnostics Thrombotic thrombocytopenic purpura – Trials in Disease Nephrotic syndrome – Diagnostics Ewing’s sarcoma recurrent – Basic Information Thrombotic thrombocytopenic purpura Pemphigus – Treatment Adrenocortical carcinoma – Trials in Disease Isodicentric chromosome 15 syndrome – Trials in Disease Pituitary-dependent Cushing’s syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fludarabine Phosphate Selgantolimod Amifostine Thiol Dmd06-Mab Glatiramer Acetate Bendamustine Hydrochloride Bi 764524 Daplusiran Argon TRIACYLGLYCEROL LIPASE Rbl005.3 Atorvastatin Calcium FLUCLOXACILLIN SODIUM Pal1-15 Acetate VANADIUM OXIDE SULFATE Zofenopril Calcium Abacavir Sulfate Potato Starch Quizartinib Dihydrochloride Melphalan Flufenamide More therapies…

    Learn about Your Condition

    Transitional cell carcinoma Streptococcal infection Anaemia of pregnancy Hepatotoxicity Pulmonary venous thrombosis Ebola disease PIK3CA-activated mutation Mitral valve incompetence Renal cancer Endometrial cancer recurrent Tympanic membrane perforation Intracranial aneurysm Breast angiosarcoma metastatic Diabetic foot infection Hepatorenal syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Long-term safety and outcomes of repeated rituximab in adults with schizophrenia spectrum disorder

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Rituximab
    Sweden

  • Safety and Tolerability of Oral SUN-627 in Adults with Non‑Active Progressive Multiple Sclerosis (SPMS/PPMS) – Phase 2a Study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Finland

  • Diagnostic Accuracy of [18F]FAPI-74 PET/CT for Detecting Metastasis and Assessing Treatment Response in Gastric Cancer Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Gastric cancer
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    Finland

  • Enoxaparin or drug combination versus no anticoagulant treatment for incidental subsegmental pulmonary embolism in cancer patients

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pulmonary embolism
    Investigated Drugs:
    • Tinzaparin Sodium
    • Dalteparin Sodium
    • Rivaroxaban
    Denmark

  • Phase I/II Study of ubamatamab plus drug combination in patients with ovarian cancer who have poor response to first‑line chemotherapy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Ubamatamab
    • Bevacizumab
    • Carboplatin
    France

  • Safety and Efficacy of AST-004 in Patients with Mild Complicated Traumatic Brain Injury

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Craniocerebral injury
    The Netherlands
Previous Page
1 … 700 701 702 703 704 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!